Top 10: Endocrinology Network 2016

SGLT2 inhibitors, GLP-1 receptor agonists, insulin, and more – we’ve compiled a list of this year’s most popular articles on Endocrinology Network.

Related Content:

Diabetes

Dapagliflozin Effective for Reducing CV Risk in Diabetes, Irrespective of Kidney Function

Race, Gender, & Income Influence Access to SGLT2 Inhibitors Among US Patients

Low-Intensity Walking Program Fails to Show Benefit for Peripheral Artery Disease